Strategic Analysis of the Multiplex Assay Market

1. Multiplex Assay Market The Multiplex Assay Market size is predicted to reach USD 153.9 million with a CAGR of 6.4% by 2030. Next Move Strategy Consulting

2. Agenda • Market Overview • Market Segmentation • Regional Analysis • Key Market Players • Key Highlights Next Move Strategy Consulting

3. Market Overview • In a multiplex assay test, multiple analytes are simultaneously measured in a single experiment, thereby amplifying multiple targets in a single PCR (Polymerase Chain Reaction). • Multiplex assay tests hold wide applications in clinical laboratories, hospitals, pharmaceutical companies, research institutes, and others; for mutation analysis, DNA & RNA detection, pathogen detection, forensic studies, linkage analysis and other such investigations. • Multiplex Assay market is proliferating, owing to various benefits offered by these automated tests such as, requirement of minimal substrates, different arrays measured in a single trial, faster results, easy operations, reduced labor costs, and higher operational efficacy. • High cost of the equipment and stringent regulatory standards are likely to hamper the growth of multiplex assay market. Next Move Strategy Consulting

4. Market Segmentation • By Product • Multiplex Assay Reagents & Consumables • Multiplex Assay Instruments & Accessories • Multiplex Assay Software & Services • By Technology • Multiplex PCR • Multiplex Protein Microarray • Others • By Type • Nucleic Acid-based Multiplex Assays • Protein-based Multiplex Assays • Others • By Application • Companion Diagnostics • Research & Development • Clinical Diagnostics • By End User • Hospitals • Clinical Laboratories • Research Institutes • Pharmaceuticals & Biotechnological Companies Next Move Strategy Consulting

5. Regional Analysis • North America • The U.S. • Canada • Mexico • Asia-Pacific • China • India • Japan • South Korea • Australia • Rest of Asia-Pacific • RoW • UAE • Saudi Arabia • South Africa • Brazil • Remaining Countries • Europe • The UK • Germany • France • Italy • Spain • Denmark • Netherlands • Finland • Sweden • Norway • Russia Next Move Strategy Consulting

6. Key Market Players • Thermo Fisher Scientific Inc. • Luminex Corporation • Bio-Rad Laboratories Inc. • Illumina Inc. • Becton, Dickinson and Company • QIAGEN N.V. • Seegene Inc. • Abcam PLC • Randox Laboratories Ltd • Meso Scale Diagnostics LLC Next Move Strategy Consulting

7. Key Highlights • Technological Advancements: Innovations such as microarray, Luminex xMAP technology, and polymerase chain reaction (PCR)-based multiplex assays are driving growth by enabling complex analyses with higher sensitivity and specificity. • Applications: Multiplex assays are increasingly used in diverse fields, including oncology, infectious diseases, and personalized medicine, allowing for comprehensive analysis and better patient management. • Demand for Personalized Medicine: The shift towards personalized medicine is boosting the market, as multiplex assays provide detailed molecular profiles that are crucial for tailoring individualized treatments. • Regional Insights: North America holds a significant market share, supported by advanced healthcare infrastructure and strong R&D activities. Next Move Strategy Consulting

8. THANK YOU Next Move Strategy Consulting Follow us www.nextmsc.com info@nextmsc.com +1-217-650-7991 Access Full Report - https://www.nextmsc.com/report/multiplex-assay-market Next Move Strategy Consulting